Home
About KRI
Mission & History
Need for Research
Support the KRI
Newsletters
Announcements
Community
Community Connection
Resources
People
Director
Investigators
Research & Administrative Staff
Patient Advisory Committee
Scientific Advisory Committee
Former Scientific Advisory Committee Members
Research
Join A Study
Active Research Studies
Completed Research Studies
Kidney Precision Medicine Project
Blossom Study
Seattle Kidney Study
Publications
Collaborating Organizations
Research Tools
Vitamin D Calculator
Urine Phosphate Calculator
Contact Us
General Inquiries & Location
Employment
News Media
SIGN UP FOR OUR NEWSLETTER
Home
About KRI
Mission & History
Need for Research
Support the KRI
Newsletters
Announcements
Community
Community Connection
Resources
People
Director
Investigators
Research & Administrative Staff
Patient Advisory Committee
Scientific Advisory Committee
Former Scientific Advisory Committee Members
Research
Join A Study
Active Research Studies
Completed Research Studies
Kidney Precision Medicine Project
Blossom Study
Seattle Kidney Study
Publications
Collaborating Organizations
Research Tools
Vitamin D Calculator
Urine Phosphate Calculator
Contact Us
General Inquiries & Location
Employment
News Media
JAK1/JAK2 inhibition by baricitinib in diabetic kidney disease: results from a Phase 2 randomized controlled clinical trial.
« US Renal Data System 2017 Annual Data Report: Epidemiology of Kidney Disease in the United States | previous article
next article | Proximal Tubular Secretory Clearance: A Neglected Partner of Kidney Function. »
